Investor's Business Daily on MSN11h
Is Microsoft Stock, After Breaking A 4-Week Losing Streak, A Buy In January? Here's What The Fundamentals, Chart Action Say Now
Microsoft started the new year with a small gain year to date, then lost it in recent days. But last week's 2.4% rebound ...
Investor's Business Daily on MSN11h
Dow Jones Futures Rise On Netflix, 'Stargate' AI Plan; Trump Threatens China Tariffs
Dow Jones futures were little changed while S&P 500 futures and Nasdaq futures rose slightly. Netflix surged late on strong ...
Hosted on MSN13h
Interactive Brokers Stock Signals Breakout As Earnings Accelerate
Interactive Brokers beat earnings estimates for the fourth quarter late Tuesday as strong stock markets boosted trading and ...
Investor's Business Daily on MSN13h
SkyWest, IBD Stock Of The Day, Tests Breakout Ahead Of Earnings As Airlines Fly
SkyWest Airlines is IBD Stock Of The Day. SKYW stock is flirting with a breakout buy point heading into earnings.
SkyWest, IBD Stock Of The Day, Breaks Out Ahead Of Earnings As Airlines Fly
SkyWest is the IBD Stock Of The Day for Tuesday. Analysts expect SkyWest earnings will soar 327% to $1.79 per share from 42 ...
Hosted on MSN14h
Stock Market Today: Dow Jones Jumps 538 Points As Trump Stock Dives; Cathie Wood Loads Up On This AI Play (Live Coverage)
The Dow Jones rallied on the stock market today amid moves by President Donald Trump. Cathie Wood snapped up a rebounding AI ...
Odyssey Therapeutics Begins IPO Rollout
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.